Phillip Gutry

Phillip Gutry

Geen lopende functies
52 jaar
Health Technology
Finance
Consumer Services

Profiel

Phillip P.
Gutry
worked as a Director of Corporate Development at Gilead Sciences, Inc. from 2006 to 2011.
He then worked as a Principal at MPM BioImpact, Inc. from 2011 to 2015.
From 2015 to 2018, he was an Executive Director of Business Development at Regeneron Pharmaceuticals, Inc. He also served as a Director at Potenza Therapeutics, Inc. and Amphivena Therapeutics, Inc. Additionally, he was an Independent Director at Avalo Therapeutics, Inc. from 2015 to 2021.
From 2018 to 2020, he was the Chief Business Officer at Kronos Bio, Inc. and later served as the CFO, Chief Business & Accounting Officer at Graphite Bio, Inc. Mr. Gutry received his undergraduate degree from Dartmouth College and his MBA from The Wharton School of the University of Pennsylvania.

Eerdere bekende functies van Phillip Gutry

BedrijvenFunctieEinde
AVALO THERAPEUTICS, INC. Directeur/Bestuurslid 01-11-2021
KRONOS BIO, INC. Corporate Officer/Principal 01-10-2020
REGENERON PHARMACEUTICALS, INC. Corporate Officer/Principal 01-10-2018
Private Equity Investor 01-06-2015
GILEAD SCIENCES, INC. Corporate Officer/Principal 01-05-2011
Ervaring van Phillip Gutry in detail bekijken

Opleiding van Phillip Gutry

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

64

Eerstegraads connecties

12

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit12

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Services

Finance

Health Technology

Retail Trade

Consumer Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Phillip Gutry
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU